Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹844Cr
Rev Gr TTM
Revenue Growth TTM
11.11%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

BODALCHEM
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -34.8 | -27.6 | -17.8 | 5.6 | 1.0 | 26.9 | 29.9 | 31.0 | 14.6 | 7.6 | 12.1 | 10.4 |
| 363 | 310 | 307 | 315 | 368 | 388 | 396 | 399 | 404 | 407 | 457 | 468 |
Operating Profit Operating ProfitCr |
| 6.9 | 6.7 | 7.1 | 7.0 | 6.4 | 8.2 | 7.6 | 10.0 | 10.5 | 10.5 | 4.8 | 4.5 |
Other Income Other IncomeCr | 4 | 9 | 6 | 5 | 5 | 2 | 5 | 1 | 2 | 4 | 20 | 15 |
Interest Expense Interest ExpenseCr | 12 | 13 | 13 | 12 | 16 | 21 | 20 | 20 | 21 | 22 | 20 | 19 |
Depreciation DepreciationCr | 15 | 15 | 14 | 15 | 17 | 17 | 17 | 17 | 17 | 18 | 17 | 17 |
| 5 | 3 | 2 | 2 | -2 | -1 | 1 | 8 | 12 | 13 | 6 | 0 |
| 2 | 1 | 0 | 1 | -4 | 0 | 1 | 3 | -3 | 3 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | -90.3 | -90.2 | -87.9 | -59.7 | -27.4 | -153.4 | -119.3 | 453.1 | 610.8 | 907.6 | 2,595.8 | -95.6 |
| 0.7 | 0.7 | 0.4 | 0.3 | 0.5 | -0.3 | -0.1 | 1.2 | 3.2 | 2.1 | 1.3 | 0.1 |
| 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | -0.1 | 0.0 | 0.4 | 1.1 | 0.8 | 0.5 | 0.0 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 8.9 | -12.9 | 35.7 | -7.5 | 24.6 | -3.4 | -10.8 | 67.6 | -23.4 | -11.4 | 25.1 | 7.5 |
| 861 | 760 | 1,008 | 948 | 1,187 | 1,237 | 1,140 | 1,835 | 1,441 | 1,284 | 1,578 | 1,735 |
Operating Profit Operating ProfitCr |
| 17.6 | 16.5 | 18.3 | 17.0 | 16.6 | 10.0 | 7.1 | 10.7 | 8.5 | 7.9 | 9.6 | 7.5 |
Other Income Other IncomeCr | 5 | 19 | 15 | 9 | 13 | 10 | 16 | -2 | 12 | 9 | 2 | 41 |
Interest Expense Interest ExpenseCr | 27 | 12 | 9 | 5 | 9 | 19 | 17 | 29 | 41 | 54 | 82 | 82 |
Depreciation DepreciationCr | 22 | 26 | 29 | 12 | 21 | 28 | 30 | 47 | 53 | 60 | 69 | 69 |
| 139 | 131 | 204 | 186 | 219 | 101 | 55 | 142 | 51 | 5 | 19 | 30 |
| 47 | 45 | 71 | 62 | 77 | 15 | 16 | 43 | 13 | -2 | 1 | 0 |
|
| 204.3 | -6.3 | 54.6 | -6.3 | 14.1 | -39.5 | -53.8 | 148.1 | -61.5 | -83.0 | 186.0 | 63.5 |
| 8.8 | 9.4 | 10.8 | 10.9 | 10.0 | 6.3 | 3.2 | 4.8 | 2.4 | 0.5 | 1.1 | 1.6 |
| 8.4 | 7.9 | 12.2 | 10.6 | 11.6 | 7.1 | 3.3 | 8.8 | 3.0 | 0.5 | 1.5 | 2.4 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 22 | 22 | 22 | 24 | 24 | 24 | 24 | 25 | 25 | 25 | 25 | 25 |
| 135 | 213 | 341 | 673 | 805 | 864 | 957 | 1,028 | 1,053 | 1,057 | 1,080 | 1,097 |
Current Liabilities Current LiabilitiesCr | 254 | 259 | 316 | 348 | 411 | 495 | 610 | 804 | 621 | 694 | 767 | 768 |
Non Current Liabilities Non Current LiabilitiesCr | 99 | 16 | 26 | 29 | 58 | 38 | 159 | 266 | 422 | 511 | 481 | 423 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 323 | 307 | 405 | 537 | 616 | 758 | 871 | 1,131 | 851 | 813 | 898 | 873 |
Non Current Assets Non Current AssetsCr | 211 | 202 | 302 | 538 | 683 | 713 | 885 | 992 | 1,270 | 1,474 | 1,455 | 1,440 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 198 | 131 | 104 | 7 | 186 | 10 | -13 | -14 | 290 | 204 | 114 |
Investing Cash Flow Investing Cash FlowCr | -35 | -23 | -68 | -256 | -128 | -81 | -168 | -170 | -310 | -262 | -37 |
Financing Cash Flow Financing Cash FlowCr | -162 | -109 | -23 | 236 | -51 | 76 | 178 | 181 | 33 | 81 | -73 |
|
Free Cash Flow Free Cash FlowCr | 162 | 107 | 45 | -221 | 38 | -43 | -191 | -170 | -29 | -29 | 69 |
| 215.4 | 152.6 | 78.0 | 5.7 | 130.8 | 11.1 | -32.7 | -13.7 | 762.2 | 3,157.3 | 615.0 |
CFO To EBITDA CFO To EBITDA% | 107.4 | 87.6 | 45.9 | 3.6 | 78.8 | 6.9 | -15.0 | -6.2 | 217.4 | 184.5 | 68.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 368 | 799 | 1,748 | 1,486 | 1,549 | 517 | 1,102 | 1,235 | 725 | 922 | 737 |
Price To Earnings Price To Earnings | 4.0 | 9.4 | 13.2 | 12.1 | 10.8 | 5.9 | 26.3 | 11.8 | 19.1 | 143.7 | 39.8 |
Price To Sales Price To Sales | 0.3 | 0.9 | 1.4 | 1.3 | 1.1 | 0.4 | 0.9 | 0.6 | 0.5 | 0.7 | 0.4 |
Price To Book Price To Book | 2.4 | 3.4 | 4.8 | 2.1 | 1.9 | 0.6 | 1.1 | 1.2 | 0.7 | 0.8 | 0.7 |
| 3.1 | 6.3 | 8.3 | 8.5 | 7.2 | 5.5 | 17.8 | 8.6 | 11.0 | 16.2 | 9.7 |
Profitability Ratios Profitability Ratios |
| 37.1 | 37.3 | 35.4 | 38.2 | 37.8 | 35.8 | 35.2 | 44.0 | 43.1 | 49.8 | 49.2 |
| 17.6 | 16.5 | 18.3 | 17.0 | 16.6 | 10.0 | 7.1 | 10.7 | 8.5 | 7.9 | 9.6 |
| 8.8 | 9.4 | 10.8 | 10.9 | 10.0 | 6.3 | 3.2 | 4.8 | 2.4 | 0.5 | 1.1 |
| 45.6 | 37.8 | 41.5 | 21.9 | 22.9 | 10.4 | 5.0 | 9.9 | 5.0 | 3.0 | 5.0 |
| 58.6 | 36.6 | 36.6 | 17.9 | 17.1 | 9.7 | 4.0 | 9.4 | 3.5 | 0.6 | 1.7 |
| 17.2 | 16.9 | 18.8 | 11.6 | 10.9 | 5.8 | 2.3 | 4.7 | 1.8 | 0.3 | 0.8 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Bodal Chemicals Limited is India’s largest integrated manufacturer of **dyestuffs** and **dye intermediates**, currently undergoing a strategic transformation into a diversified specialty chemicals powerhouse. With a "foundational to global" integration strategy, the company operates a vertically integrated business model that spans from basic chemicals to high-performance colorants and benzene derivatives.
### **The Integrated Value Chain: "Foundational to Global"**
Bodal’s competitive moat is built on a high degree of backward and forward integration. Approximately **40%** of basic chemicals and **40%** of dye intermediates are consumed captively, ensuring raw material security and cost-efficiency.
| Vertical | Key Products | Strategic Role | FY25 Revenue Share |
|:---|:---|:---|:---|
| **Dye Intermediates** | Vinyl Sulphone, H-Acid, Gamma Acid, K-Acid | Operational backbone; **40%** captive consumption for dyestuffs. | **39%** |
| **Dyestuffs** | Reactive, Acid, and Direct Dyes (175+ products) | Forward integration serving textile (**80%** of demand), leather, and paper. | **29%** |
| **Chlor-Alkali** | Caustic Soda, Chlorine, Hydrogen, TCCA | Diversified revenue stream; serves water treatment and hygiene. | **20%** |
| **Basic Chemicals** | Sulphuric Acid, Thionyl Chloride, Acetanilide | Backward integration; **40-50%** captive use. | **5%** |
| **Benzene Downstream** | MCB, PNCB, ONCB, MNCB, DCB | New high-value specialty segment for agrochemicals and pharma. | **1% (Scaling)** |
---
### **Manufacturing Footprint & Technological Infrastructure**
Bodal operates **8 active manufacturing facilities** primarily located in India’s western chemical belt, providing logistical advantages via proximity to major seaports (Mundra, Hazira, Nhava Sheva).
* **Total Capacity:** Approximately **470,000 MTPA** across all segments.
* **Saykha Greenfield Facility:** A **₹540 crore** state-of-the-art plant with **63,000 MTPA** capacity for Benzene derivatives. It features world-class German **Adiabatic Nitration** and Swiss **Continuous Crystallisation** technologies.
* **Strategic Consolidation:** In **2024-25**, the company permanently decommissioned legacy units at **Vatva (Units I, II, and III)** to optimize costs and shift production to more efficient, automated facilities in **Vadodara** and **Kosi**.
* **R&D and Distribution:** Operates **2 In-house R&D labs** in Vadodara and a global distribution network of **10 Depots** (6 in India, 1 each in China, Turkey, Bangladesh, and Indonesia).
---
### **Strategic Realignment & Asset Optimization**
The company is actively pivoting from volume-driven intermediates to value-added specialty chemicals while rationalizing its balance sheet.
* **Asset Monetization:** In **February 2026**, the board approved the sale of **40 acres** of surplus land at Unit-12. The buyers will establish units to consume byproduct **Chlorine** and **Hydrogen**, creating a circular ecosystem and ensuring uninterrupted production.
* **Product Diversification:** Entry into **TCCA (Trichloroisocyanuric Acid)** for water treatment. Profitability is expected to rise following the imposition of a **5-year anti-dumping duty** on Chinese imports in **March 2025**, potentially adding **₹50-₹60 crore** to annual turnover.
* **Capital Infusion:** Approved the issuance of **1,00,00,000 share warrants** at **₹85.60** per warrant (totaling **₹85.60 crore**) to non-promoters in **April 2024** to fund working capital and debt reduction.
* **Corporate Streamlining:** Completed the merger of **SPS Processors** and **Trion Chemicals** into Bodal Chemicals to simplify the corporate structure.
---
### **Financial Performance & Segment Analysis**
While the company has faced headwinds from global demand suppression and high interest liabilities, **9MFY26** showed a recovery trend with **12% YoY revenue growth**.
**Consolidated Financial Summary:**
| Metric (₹ Crore) | 9MFY26 | FY25 | FY24 |
| :--- | :--- | :--- | :--- |
| **Total Revenue** | **1,463.3** | **1,756.7** | **1,419.4** |
| **EBITDA** | **131.7** | **170.7** | **119.5** |
| **PAT** | **15.8** | **18.5** | **6.5** |
| **EBITDA Margin** | **9.0%** | **9.7%** | **8.4%** |
**Key Segment Highlights:**
* **Chlor-Alkali:** Revenue reached **₹255.3 crore** for **9MFY26**. This follows a volatile **FY24** where revenue declined **18%** despite a **17% volume increase** due to crashing Caustic Soda prices.
* **Benzene Downstream:** Estimated revenue potential of **₹320 crore** at optimum utilization with **12% to 15%** EBITDA margins.
* **Exceptional Items:** Recognized profits of **₹10.66 crore** and **₹7.23 crore** in **FY26** from the sale of inoperative Vatva units.
---
### **Global Subsidiary Network & Market Reach**
Bodal serves over **600 customers** across **35+ countries**, with exports contributing approximately **28%** of total revenue.
* **Sener Boya (Turkey):** A regional hub for Europe; currently navigating **hyperinflationary accounting (Ind AS 29)** which resulted in a **₹1.45 crore** debit in mid-2025.
* **PT Bodal Indonesia:** A high-growth marketing arm reporting **64% YoY** revenue growth.
* **BCTPL (India):** Domestic trading arm reinitiated in **FY25** for opportunity-led arbitrage.
* **Bodal China & Bodal Bangla:** Strategic outposts serving the world's largest chemical and textile hubs.
---
### **Sustainability, ESG & Compliance**
Bodal is committed to high environmental standards, essential for maintaining its status as a preferred global supplier.
* **Environmental Tech:** Operates **Zero Liquid Discharge (ZLD)** systems; features the world’s first **Brine Treatment Plant** using AMBC technology at Unit-VII.
* **Energy Efficiency:** Awarded the **National Energy Conservation Award 2024** (Second Prize) in the Chlor-Alkali sector.
* **Certifications:** ISO 9001, 14001, 45001; **Bluesign** System Partner; GOTS, ZDHC, and BEHIVE certified.
* **Supply Chain:** Successfully shifted from China-dependency to **~90% local sourcing** within Gujarat.
---
### **Risk Profile & Mitigation Strategies**
The company manages a complex risk landscape through a formal Risk Management Committee.
* **Macro & Geopolitical:** Exposure to hyperinflation in Turkey and political instability in Bangladesh.
* **Financial Leverage:** Total debt stood at **₹896.97 crore** (March 2024). Credit ratings were adjusted to **IND BBB+/Negative** due to performance deterioration and high capex-related interest costs (**~₹3 crore/month**).
* **Regulatory & Labor:** The **New Labour Code (Nov 2025)** increased gratuity liabilities by **₹1.8 crore**. Environmental compliance costs typically range between **1%–2%** of sales.
* **Commodity Volatility:** Susceptibility to price swings in **Aniline oil, Naphthalene, and Sulphur**.
**Mitigation Table:**
| Risk Factor | Mitigation Action |
| :--- | :--- |
| **Resource Scarcity** | **5 MW** Co-generation and **1.73 MW** waste heat recovery plants. |
| **Chinese Competition** | Secured **Anti-Dumping Duty** on TCCA imports (March 2025). |
| **Safety Risks** | Implementation of **HIRA** and **Quantitative Risk Assessment** for toxic chemicals. |
| **Currency Risk** | Use of derivative forward contracts strictly for hedging **USD/EURO** exposure. |